APA (7th ed.) Citation

Fushimi, A., Tabei, I., Fuke, A., Okamoto, T., & Takeyama, H. High-Dose Toremifene as a Promising Candidate Therapy for Hormone Receptor-Positive Metastatic Breast Cancer with Secondary Resistance to Aromatase Inhibitors. Wiley.

Chicago Style (17th ed.) Citation

Fushimi, Atsushi, Isao Tabei, Azusa Fuke, Tomoyoshi Okamoto, and Hiroshi Takeyama. High-Dose Toremifene as a Promising Candidate Therapy for Hormone Receptor-Positive Metastatic Breast Cancer with Secondary Resistance to Aromatase Inhibitors. Wiley.

MLA (9th ed.) Citation

Fushimi, Atsushi, et al. High-Dose Toremifene as a Promising Candidate Therapy for Hormone Receptor-Positive Metastatic Breast Cancer with Secondary Resistance to Aromatase Inhibitors. Wiley.